{"id":"https://openalex.org/W4416066792","doi":"https://doi.org/10.1681/asn.20251m9dyn78","title":"Baseline Characteristics of ASSIST: Phase 2 Crossover Trial of Atrasentan in Adults with IgAN on SGLT2 Inhibitors","display_name":"Baseline Characteristics of ASSIST: Phase 2 Crossover Trial of Atrasentan in Adults with IgAN on SGLT2 Inhibitors","publication_year":2025,"publication_date":"2025-10-01","ids":{"openalex":"https://openalex.org/W4416066792","doi":"https://doi.org/10.1681/asn.20251m9dyn78"},"language":"en","primary_location":{"id":"doi:10.1681/asn.20251m9dyn78","doi":"https://doi.org/10.1681/asn.20251m9dyn78","is_oa":false,"landing_page_url":"https://doi.org/10.1681/asn.20251m9dyn78","pdf_url":null,"source":{"id":"https://openalex.org/S115693375","display_name":"Journal of the American Society of Nephrology","issn_l":"1046-6673","issn":["1046-6673","1533-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315620","host_organization_name":"American Society of Nephrology","host_organization_lineage":["https://openalex.org/P4310315620"],"host_organization_lineage_names":["American Society of Nephrology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009128263","display_name":"Amy K. Mottl","orcid":"https://orcid.org/0000-0002-4258-1726","observed_orcids":["https://orcid.org/0000-0002-4258-1726"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amy K. Mottl","raw_affiliation_strings":["Division of Nephrology and Hypertension, University of North Carolina, Chapel Hill, North Carolina, United States;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Nephrology and Hypertension, University of North Carolina, Chapel Hill, North Carolina, United States;","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064339436","display_name":"Gianna Mastroianni Kirsztajn","orcid":"https://orcid.org/0000-0003-1317-4109","observed_orcids":["https://orcid.org/0000-0003-1317-4109"]},"institutions":[{"id":"https://openalex.org/I88273585","display_name":"Universidade Federal de S\u00e3o Paulo","ror":"https://ror.org/02k5swt12","country_code":"BR","type":"education","lineage":["https://openalex.org/I88273585"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Gianna Mastroianni-Kirsztajn","raw_affiliation_strings":["Department of Medicine, Federal University of S\u00e3o Paulo, Sao Paulo, Brazil;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Federal University of S\u00e3o Paulo, Sao Paulo, Brazil;","institution_ids":["https://openalex.org/I88273585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031510699","display_name":"Irene L. Noronha","orcid":"https://orcid.org/0000-0002-3208-4435","observed_orcids":["https://orcid.org/0000-0002-3208-4435"]},"institutions":[{"id":"https://openalex.org/I17974374","display_name":"Universidade de S\u00e3o Paulo","ror":"https://ror.org/036rp1748","country_code":"BR","type":"education","lineage":["https://openalex.org/I17974374"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Irene L. Noronha","raw_affiliation_strings":["Division of Nephrology, University of S\u00e3o Paulo School of Medicine, S\u00e3o Paulo, Brazil;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Nephrology, University of S\u00e3o Paulo School of Medicine, S\u00e3o Paulo, Brazil;","institution_ids":["https://openalex.org/I17974374"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037021026","display_name":"Soo Kun Lim","orcid":"https://orcid.org/0000-0001-7589-5150","observed_orcids":["https://orcid.org/0000-0001-7589-5150"]},"institutions":[{"id":"https://openalex.org/I33849332","display_name":"University of Malaya","ror":"https://ror.org/00rzspn62","country_code":"MY","type":"education","lineage":["https://openalex.org/I33849332"]}],"countries":["MY"],"is_corresponding":false,"raw_author_name":"Soo Kun Lim","raw_affiliation_strings":["Department of Medicine, University of Malaya, Kuala Lumpur, Malaysia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of Malaya, Kuala Lumpur, Malaysia;","institution_ids":["https://openalex.org/I33849332"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046692355","display_name":"Jos\u00e9 Luis G\u00f3rriz","orcid":"https://orcid.org/0000-0002-1134-9051","observed_orcids":["https://orcid.org/0000-0002-1134-9051"]},"institutions":[{"id":"https://openalex.org/I16097986","display_name":"Universitat de Val\u00e8ncia","ror":"https://ror.org/043nxc105","country_code":"ES","type":"education","lineage":["https://openalex.org/I16097986"]},{"id":"https://openalex.org/I4210094406","display_name":"Hospital Cl\u00ednico Universitario de Valencia","ror":"https://ror.org/00hpnj894","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210094406"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jose L. Gorriz","raw_affiliation_strings":["Nephrology Department, Hospital Cl\u00ednico Universitario de Valencia, University of Valencia, Valencia, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nephrology Department, Hospital Cl\u00ednico Universitario de Valencia, University of Valencia, Valencia, Spain;","institution_ids":["https://openalex.org/I16097986","https://openalex.org/I4210094406"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085805044","display_name":"Sradha S. Kotwal","orcid":"https://orcid.org/0000-0002-3294-4087","observed_orcids":["https://orcid.org/0000-0002-3294-4087"]},"institutions":[{"id":"https://openalex.org/I4210108821","display_name":"Prince of Wales Hospital","ror":"https://ror.org/022arq532","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210108821"]},{"id":"https://openalex.org/I4210110309","display_name":"The George Institute for Global Health","ror":"https://ror.org/023331s46","country_code":"AU","type":"facility","lineage":["https://openalex.org/I4210110309"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Sradha S. Kotwal","raw_affiliation_strings":["Department of Nephrology, Prince of Wales Hospital, Sydney, New South Wales, Australia;","The George Institute for Global Health, Sydney, New South Wales, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nephrology, Prince of Wales Hospital, Sydney, New South Wales, Australia;","institution_ids":["https://openalex.org/I4210108821"]},{"raw_affiliation_string":"The George Institute for Global Health, Sydney, New South Wales, Australia;","institution_ids":["https://openalex.org/I4210110309"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028114814","display_name":"Sung Gyun Kim","orcid":"https://orcid.org/0000-0002-5034-0527","observed_orcids":["https://orcid.org/0000-0002-5034-0527"]},"institutions":[{"id":"https://openalex.org/I4210159787","display_name":"Hallym University Sacred Heart Hospital","ror":"https://ror.org/04ngysf93","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I4210159787","https://openalex.org/I4210167048"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Sung Gyun Kim","raw_affiliation_strings":["Hallym University Sacred Heart Hospital, Anyang-si, Gyeonggi-do, Korea (the Republic of);"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hallym University Sacred Heart Hospital, Anyang-si, Gyeonggi-do, Korea (the Republic of);","institution_ids":["https://openalex.org/I4210159787"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055078486","display_name":"Jonathan Barratt","orcid":"https://orcid.org/0000-0002-9063-7229","observed_orcids":["https://orcid.org/0000-0002-9063-7229"]},"institutions":[{"id":"https://openalex.org/I153648349","display_name":"University of Leicester","ror":"https://ror.org/04h699437","country_code":"GB","type":"education","lineage":["https://openalex.org/I153648349"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jonathan Barratt","raw_affiliation_strings":["University of Leicester, Leicester, England, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Leicester, Leicester, England, United Kingdom;","institution_ids":["https://openalex.org/I153648349"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087042179","display_name":"Yasmin Ghanshyam Brahmbhatt","orcid":"https://orcid.org/0000-0001-8718-9368","observed_orcids":["https://orcid.org/0000-0001-8718-9368"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yasmin Brahmbhatt","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, United States;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, United States;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091798031","display_name":"Greggory Housler","orcid":"https://orcid.org/0000-0002-1151-7166","observed_orcids":["https://orcid.org/0000-0002-1151-7166"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Greggory Joseph Housler","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, United States;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, United States;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100546396","display_name":"Rong Jiao","orcid":"https://orcid.org/0000-0002-3409-2826","observed_orcids":["https://orcid.org/0000-0002-3409-2826"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rong Jiao","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, United States;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, United States;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031624913","display_name":"Hiddo J.L. Heerspink","orcid":"https://orcid.org/0000-0002-3126-3730","observed_orcids":["https://orcid.org/0000-0002-3126-3730"]},"institutions":[{"id":"https://openalex.org/I1334415907","display_name":"University Medical Center Groningen","ror":"https://ror.org/03cv38k47","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I1334415907"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Hiddo Jan L. Heerspink","raw_affiliation_strings":["Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, Netherlands","institution_ids":["https://openalex.org/I1334415907"]}]}],"institutions":[],"countries_distinct_count":8,"institutions_distinct_count":11,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.7012,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.74783152,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":96},"biblio":{"volume":"36","issue":"10S","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.9545999765396118,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.9545999765396118,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.03359999880194664,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10373","display_name":"Renal Transplantation Outcomes and Treatments","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2747","display_name":"Transplantation"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atrasentan","display_name":"atrasentan","score":0.9649999737739563},{"id":"https://openalex.org/keywords/iga-nephropathy","display_name":"IgA nephropathy","score":0.9229999780654907},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.8880000114440918},{"id":"https://openalex.org/keywords/endothelin-a-receptor-antagonist","display_name":"endothelin A receptor antagonist","score":0.9620000123977661},{"id":"https://openalex.org/keywords/proteinuria","display_name":"proteinuria","score":0.9039999842643738},{"id":"https://openalex.org/keywords/baseline-characteristics","display_name":"baseline characteristics","score":0.6489999890327454},{"id":"https://openalex.org/keywords/renin-angiotensin-system-inhibitors","display_name":"renin-angiotensin system inhibitors","score":0.8539999723434448},{"id":"https://openalex.org/keywords/chronic-kidney-disease","display_name":"chronic kidney disease","score":0.6230000257492065},{"id":"https://openalex.org/keywords/urine-protein-creatinine-ratio","display_name":"urine protein-to-creatinine ratio","score":0.6800000071525574}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7434999942779541},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.6682000160217285},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.5893999934196472},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.42239999771118164},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3889999985694885},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38040000200271606},{"id":"https://openalex.org/C122507166","wikidata":"https://www.wikidata.org/wiki/Q628906","display_name":"Crossover","level":2,"score":0.3783999979496002},{"id":"https://openalex.org/C77411442","wikidata":"https://www.wikidata.org/wiki/Q181100","display_name":"Urinary system","level":2,"score":0.357699990272522},{"id":"https://openalex.org/C2778653478","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Kidney disease","level":2,"score":0.3492000102996826},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.3458000123500824},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3449000120162964},{"id":"https://openalex.org/C12725497","wikidata":"https://www.wikidata.org/wiki/Q810247","display_name":"Baseline (sea)","level":2,"score":0.3345000147819519},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.32760000228881836},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.27320000529289246}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1681/asn.20251m9dyn78","doi":"https://doi.org/10.1681/asn.20251m9dyn78","is_oa":false,"landing_page_url":"https://doi.org/10.1681/asn.20251m9dyn78","pdf_url":null,"source":{"id":"https://openalex.org/S115693375","display_name":"Journal of the American Society of Nephrology","issn_l":"1046-6673","issn":["1046-6673","1533-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315620","host_organization_name":"American Society of Nephrology","host_organization_lineage":["https://openalex.org/P4310315620"],"host_organization_lineage_names":["American Society of Nephrology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4380447981","https://openalex.org/W4403287054","https://openalex.org/W7142758309","https://openalex.org/W4393851446","https://openalex.org/W4403811683","https://openalex.org/W4403832245","https://openalex.org/W3172530387","https://openalex.org/W4396989830","https://openalex.org/W4229001749","https://openalex.org/W4416066924"],"abstract_inverted_index":{"Background:":[0],"Atrasentan":[1],"is":[2,34,286],"a":[3,73,124,274],"potent":[4],"and":[5,48,87,101,159,174,189,218,246,262],"highly":[6],"selective":[7],"endothelin":[8],"A":[9],"receptor":[10],"antagonist":[11],"(ERA),":[12],"granted":[13],"accelerated":[14],"approval":[15],"by":[16,288],"the":[17,29,46,51,163,168,178,260],"US":[18],"FDA":[19],"for":[20,259],"primary":[21,173],"IgAN":[22,84,271],"based":[23],"on":[24,98,107],"an":[25,113,236],"Interim":[26],"Analysis":[27],"of":[28,36,50,66,79,118,129,239,264,277],"ALIGN":[30],"(NCT04573478)":[31],"study.":[32],"SGLT2i":[33,57,102,109,119,201,247,269],"standard":[35],"care":[37],"in":[38,54,58,70,81,146,156,162,180,227,266,270],"CKD,":[39],"but":[40],"minimal":[41],"evidence":[42,258],"exists":[43],"to":[44,111,133,139,186],"support":[45],"efficacy":[47,261],"safety":[49,263],"ERA":[52],"class":[53],"combination":[55,267],"with":[56,83,91,248,268,273],"IgAN.":[59],"Here":[60],"we":[61],"describe":[62],"baseline":[63],"(BL)":[64],"characteristics":[65],"participants":[67],"(pts)":[68],"enrolled":[69],"ASSIST":[71,230],"(NCT05834738),":[72],"randomized,":[74],"double-blind,":[75],"placebo-controlled,":[76],"crossover":[77],"study":[78,255,285],"atrasentan":[80,153,265],"adults":[82],"using":[85],"RASi":[86,100,245],"SGLT2i.":[88],"Methods:":[89],"Pts":[90,105,135],"biopsy-proven":[92],"IgAN,":[93],"eGFR":[94],"\u226530":[95],"mL/min/1.73":[96],"m2,":[97],"stable":[99,108],"were":[103,136,205],"enrolled.":[104],"not":[106],"had":[110],"complete":[112],"8-week":[114],"(wk)":[115],"run-in":[116],"period":[117,158,165,194],"stabilization.":[120],"All":[121],"pts":[122,199,232,272],"needed":[123],"24-hr":[125],"total":[126],"urine":[127,249],"protein":[128,250],">0.5":[130],"g/d":[131],"prior":[132],"randomization.":[134],"randomized":[137,206],"1:1":[138],"either":[140,150],"sequence":[141,144],"AB":[142],"or":[143],"BA":[145],"which":[147],"they":[148],"received":[149],"0.75":[151],"mg":[152],"once":[154],"daily":[155],"one":[157],"matching":[160],"placebo":[161],"other":[164],"as":[166],"per":[167],"randomization":[169],"schema":[170],"(Figure).":[171],"The":[172,254,284],"secondary":[175],"endpoints":[176],"are":[177,225],"change":[179],"proteinuria":[181,278],"(24-hr":[182],"UPCR)":[183],"from":[184],"BL":[185,223],"wk":[187,190],"12":[188],"24":[191],"(in":[192],"Treatment":[193],"2),":[195],"respectively.":[196],"Results:":[197],"54":[198],"(47":[200],"stable,":[202],"7":[203],"run-in)":[204],"across":[207],"6":[208],"countries;":[209],"mean":[210],"age":[211],"47.7":[212],"years,":[213],"57.4%":[214],"male,":[215],"64.8%":[216],"white":[217],"median":[219],"UPCR":[220],"1.0":[221],"g/g.":[222],"data":[224],"shown":[226],"Table.":[228],"Conclusion:":[229],"includes":[231],"who":[233],"remain":[234],"at":[235,252],"increased":[237],"risk":[238],"kidney":[240],"failure":[241],"despite":[242],"maximally":[243],"tolerated":[244],">0.5g/d":[251],"BL.":[253],"will":[256],"provide":[257],"broad":[275],"range":[276],"levels.":[279],"Funding:":[280],"Commercial":[281],"Support":[282],"-":[283],"sponsored":[287],"Novartis":[289],"Pharmaceuticals":[290]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2025-11-10T00:00:00"}